|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
HIV |
|
��ͷ״��������Ⱦ,�� |
| ��������������� | |
|
��ǿ |
|
��Ծƽ |
| PubMed | |
|
Article by |
|
Article by |
HIV������Ⱥ��HPV��Ⱦ���о���չ
��ǿ, ��Ծƽ
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о��� �Ͼ� 210042
��������ȱ�ݲ���������Ⱥ��,��Ů��ֳ����λ����ͷ�������ĸ�Ⱦ�ʽϸߡ�����ͷ��������Ⱦ������������,����ϸ����������������ͷ��������Ⱦ��������������,��Һ����Ӧ��Ҳ��ϸ����������ǰ����֡���Ҫ���ܽ������й�������ȱ�ݲ���������ͷ��������Ⱦ�����в�ѧ������û��Ƶ��о���չ��
[2] Ahdieh L, Munoz A, Vlahov D, et al. Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and-seronegative women. Am J Epidemiol,2000, 151:1148-1157.
[3] Unger ER, Vernon SD, Lee DR, et al. Human papillomavirus type in anal epithelial lesions is influenced by human immunodeficiency virus.Arch Pathol Lab Med, 1997, 121:820-824.
[4] Gomousa-Michael M, Gialama E, Gomousas N, et al. Genital human papillomavirus infection and associated penile intraepithelial neoplasia in males infected with the human immunodeficiency virus. Acta Cytol,2000, 44:305-309.
[5] Palefsky JM, Holly EA, Ralston ML, et al. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis, 2001, 183:383-391.
[6] Piketty C, Darragh TM, Da Costa M, et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIVinfected persons in the absence of anal intercourse. Ann Intern Med,2003, 138:453-459.
[7] Silverberg MJ, Ahdieh L, Munoz A, et al. The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts. Sex Transm Dis, 2002, 29:427-435.
[8] Heard I, Tassie JM, Schmitz V,et al. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load (1). Obstet Gynecol, 2000, 96:403-409.
[9] Shamanin V, zur Hausen H, Lavergne D, et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst, 1996,88:802-811.
[10] Zbar AP, Fenger C, Efron J,et al. The pathology and molecular biology of anal intraepithelial neoplasia: comparisons with cervical and vulvar intraepithelial carcinoma. Int J Colorectal Dis, 2002, 17:203-215.
[11] Petter A, Heim K, Guger M, et al. Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 viruslike particles in human immunodeficiency virus-seropositive women. J Gen Virol, 2000, 81:701-708.
[12] Vernon SD, Hart CE, Reeves WC, et al. The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription. Virus Res, 1993, 27:133-145.
[13] Del Mistro A, Chieco Bianchi L. HPV-related neoplasias in HIV-infected individuals. Eur J Cancer, 2001, 37:1227-1235.
[14] Ellerbrock TV, Chiasson MA, Bush TJ, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA,2000, 283:1031-1037.
[15] de Sanjose S, Palefsky J. Cervical and anal HPV infections in HIV positive women and men. Virus Res, 2002, 89:201-211.
[16] Korn AP, Abercrombie PD, Foster A. Vulvar intraepithelial neoplasia in women infected with human immunodeficiency virus-1. Gynecol Oncol, 1996, 61:384-386.
[17] Palefsky JM, Holly EA, Ralston ML, et al. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis, 1998, 177:361-367.
[18] Palefsky JM, Holly EA, Ralston ML,et al. Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol, 1998, 17:320-326.
[19] Bernard C, Mougin C, Madoz L, et al. Viral co-infections in human papillomavirus-associated anogenital lesions according to the serostatus for the human immunodeficiency virus. Int J Cancer, 1992, 52:731-737.